OncoMatch/Clinical Trials/NCT07855627
Prediction Of Lymphedema In Patients With Inflammatory BreastCancer Using Preoperative Bioimpedance Measurements
Is NCT07855627 recruiting? Yes, currently enrolling (Oct 2026). Studying Neoadjuvant therapy for lymphedema.
Treatment: Neoadjuvant therapy — To find out whether the BIA test can help identify participants with IBC who are at risk for developing lymphedema.
Check if I qualifyExtracted eligibility criteria
Treatments studied
Other
Cancer type
Breast Carcinoma
Demographics
Prior therapy
Cannot have received: breast/axillary surgery
Prior breast/axillary surgery
Structured fields extracted by AI. May contain errors — verify against the official protocol.
US trial sites
- UT MD Anderson Cancer Center · Houston, Texas
Showing up to 5 US sites.
See all sites on ClinicalTrials.gov →Frequently asked questions
Is NCT07855627 currently recruiting?
Yes, this trial is currently recruiting patients.
Are there prior therapy exclusions?
Yes. Prior breast/axillary surgery disqualifies patients from enrollment.
Is this trial open to male patients?
No. This trial enrolls female patients only.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages